Monday, January 27, 2014

Morning Movers: Eli Lilly Drops on 2014 Guidance; Zale Falls on Offering

Stocks appear set for a lower open for a second consecutive day, as the government shutdown drags on.

AP

S&P 500 futures have dropped 0.1% to 1,681.70, while Dow Jones Industrial Average futures have ticked down 0.1% to 15,012.

Shares of Constellation Brands (STZ) have dropped 1.3% to $7.50 gained 1.3% to $59.03 after the maker of alcoholic beverages said it earned 96 cents a share, ahead of forecasts for 88 cents.

Vivus (VVUS) has gained 4.3% to $10.63 after Cowen upgraded it to Outperform from Hold, and Orexigen Therapeutics (OREX) rose 4% to $6.30 after Cowen started it as Outperform.

Eli Lilly (LLY) has dropped 1.3% to $49.90 after the pharmaceutical company said it hoped turn a profit in 2014.

Zale (ZLC) has dropped 5.4% to $14.90 after it announced that it would sell a large chunk of stock for a shareholder, Briefing.com said.

No comments:

Post a Comment